TipRanks

Notifications

Analysts Are Bullish on Top Healthcare Stocks: Acadia Healthcare (ACHC), Teva Pharmaceutical (TEVA)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Acadia Healthcare (ACHCResearch Report) and Teva Pharmaceutical (TEVAResearch Report) with bullish sentiments.

Acadia Healthcare (ACHC)

In a report released today, John Ransom from Raymond James maintained a Buy rating on Acadia Healthcare. The company’s shares closed last Friday at $61.56, close to its 52-week high of $68.00.

According to TipRanks.com, Ransom is a 5-star analyst with an average return of 14.6% and a 64.7% success rate. Ransom covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Alignment Healthcare, and Oak Street Health.

Currently, the analyst consensus on Acadia Healthcare is a Moderate Buy with an average price target of $67.67, which is an 8.9% upside from current levels. In a report issued on June 10, RBC Capital also maintained a Buy rating on the stock with a $74.00 price target.

See today’s analyst top recommended stocks >>

Teva Pharmaceutical (TEVA)

In a report released today, Elliot Wilbur from Raymond James initiated coverage with a Buy rating on Teva Pharmaceutical. The company’s shares closed last Friday at $10.12.

According to TipRanks.com, Wilbur has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -2.6% and a 42.3% success rate. Wilbur covers the Healthcare sector, focusing on stocks such as Amphastar Pharmaceuticals, Amneal Pharmaceuticals, and Flexion Therapeutics.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Teva Pharmaceutical with a $11.33 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.